[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346038-105":59,"doc-detail-346038-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-potential-utility-of-in-silico-approach-in-identifying-phytochemicals-against-various-targets-for-the-management-of-lung-cancer","The potential utility of in-silico approach in identifying phytochemicals against various targets for the management of lung cancer","","Research on novel treatment approaches is crucial for lung cancer because it is one of the most common and aggressive malignancies with high mortality worldwide. This review summarizes the potential advantages of using in silico methods to find phytochemicals for lung cancer treatment, emphasizing computational tools including ADMET profiling, network pharmacology, molecular docking, and machine learning. Assessed targets include EGFR, KRAS, ALK, and PD-L1, while compounds such as quercetin, curcumin, and luteolin interact with carcinogenic pathways, tumor microenvironment modulators, and apoptosis inducers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-potential-utility-of-in-silico-approach-in-identifying-phytochemicals-against-various-targets-for-the-management-of-lung-cancer/346038/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-potential-utility-of-in-silico-approach-in-identifying-phytochemicals-against-various-targets-for-the-management-of-lung-cancer/346038.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which computational tools are highlighted for identifying phytochemicals in lung cancer therapy?","Question",{"text":112,"@type":113},"The review highlights ADMET profiling, network pharmacology, molecular docking, and machine learning algorithms to support identification of potential phyto-constituents.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What molecular targets are assessed against phytochemicals?",{"text":117,"@type":113},"Targets assessed include EGFR, KRAS, ALK, and PD-L1.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the reviewed in-silico methods contribute to lung cancer drug development?",{"text":121,"@type":113},"They enable mechanistic understanding, support high-throughput screening, and promote economical drug development while bridging precision oncology and traditional medicine.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346038,1790111697,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Saini etal. Discover Oncology (2026) 17:1236 Discover Oncology  \n[https://doi.org/10.1007/s12672-026-05381-7](https://doi.org/10.1007/s12672-026-05381-7)  \nREVIEW Open Access  \nThe potential utility of in-silico approach  in identifying phytochemicals against various targets for the management of lung cancer  \nRupali Saini1, Anis Ahmad Chaudhary2, Richa Mishra3, Saurabh Gupta4, Jibrin Dauda Nggada 1, Mohamed A. M. Ali2 and Sanjay Kumar1*  \n*Correspondence:  \nSanjay Kumar [drsanjaykumar82@gmail.com](drsanjaykumar82@gmail.com)[ ](drsanjaykumar82@gmail.com)1Department of Life Science, Sharda School of Bioscience & Technology, Sharda University,  \nGreater Noida 201310, Uttar Pradesh, India  \n2Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia 3Department of Computer Engineering, Parul Institute of Engineering and Technology (PIET), Parul University, Ta. Waghodia, Vadodara 391760, Gujarat, India 4Department of Biotechnology, GLA University, Mathura, UP, India  \nAbstract  \nResearch on novel treatment approaches is crucial for lung cancer, because it isone of the most common and aggressive malignancies with high mortality in the world. The potential advantages of using in silico methods to find phytochemicals for lung cancer treatment have been summarized in this review. This also highlights the various computational tools, such as ADMET profiling, network pharmacology, molecular docking, and machine learning algorithms, involved in the identification of potential phyto-constituents for lung cancer therapy. Key molecular targets that were assessed against a range of phytochemicals that showed multi-target binding and promising pharmacokinetic properties included EGFR, KRAS, ALK, and PD-L1 . Prominent compounds such as quercetin, curcumin, and luteolin showed notable interactions with carcinogenic pathways, tumor microenvironment modulators, and apoptosis inducers. Mechanistic understanding, high-throughput screening, and economical drug development were made possible by this computational approach. This review demonstrates the potential utility of in silico techniques to bridge the gap between precision oncology and traditional medicine, as well as the intriguing function of phytochemicals as supplemental medicines in lung cancer therapy. Keywords Lung cancer, Protein targets, Signalling pathways, Phytochemicals, Therapeutics  \n1 Introduction  \nLung cancer remains one of the most prevalent and leading causes of cancer-related mortality worldwide, accounting for approximately 2.48 million new cases and 1.8 million deaths in 2022 [1]. Lung cancer poses substantial clinical challenges, as most patients are diagnosed at advanced stages, characterized by widespread metastatic potential and distinct molecular heterogeneity [2]. Non-small cell lung cancer (NSCLC) denotes the major subtype of lung cancer, revealing diverse responses to offered treatment modalities due to its significant molecular heterogeneity and involved biological characteristics [3].  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from ","cbCaiu1M4BpJS7l9","https://ap.wps.com/l/cbCaiu1M4BpJS7l9","pdf",1767418,21,"English","# Abstract\n# Introduction\n## Lung cancer burden and challenges\n## Subtypes and molecular heterogeneity\n## Therapeutic limitations and need for new options\n## Role of phytochemicals in cancer therapy\n## Computational drug discovery and in-silico methods","[{\"question\":\"Which computational tools are highlighted for identifying phytochemicals in lung cancer therapy?\",\"answer\":\"The review highlights ADMET profiling, network pharmacology, molecular docking, and machine learning algorithms to support identification of potential phyto-constituents.\"},{\"question\":\"What molecular targets are assessed against phytochemicals?\",\"answer\":\"Targets assessed include EGFR, KRAS, ALK, and PD-L1.\"},{\"question\":\"How do the reviewed in-silico methods contribute to lung cancer drug development?\",\"answer\":\"They enable mechanistic understanding, support high-throughput screening, and promote economical drug development while bridging precision oncology and traditional medicine. \"}]","The potential utility of in-silico approach in identifying phytochemicals against various targets for the management of lung cancer | PDF",1790059808,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8891392e782f0522e0435a84e55571d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3161a2ef3ec5ad57feda5c639c4fc0fd.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a51e50d30192e88e3bf17f7931815162.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f542646650374f59eb69d218abcb12ef.webp",980,1306]